CryoLife, Inc. (CRY) Tops Q2 EPS by 9c; Boosts Outlook
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Price: $17.44 -1.36%
Financial Fact:
Income tax expense: 1.74M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income tax expense: 1.74M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
CryoLife, Inc. (NYSE: CRY) reported Q2 EPS of $0.12, $0.09 better than the analyst estimate of $0.03. Revenue for the quarter came in at $33.2 million versus the consensus estimate of $32.79 million.
CryoLife, Inc. sees FY2012 EPS of $0.20-$0.23, versus the consensus of $0.17. CryoLife, Inc. sees FY2012 revenue of $129-$133 million, versus the consensus of $131.9 million.
For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.
CryoLife, Inc. sees FY2012 EPS of $0.20-$0.23, versus the consensus of $0.17. CryoLife, Inc. sees FY2012 revenue of $129-$133 million, versus the consensus of $131.9 million.
For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
